Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series.

Dimitroulas, T; Tychala, A; Katsimpourlia, E; Sidiropoulou, E; Deuteraiou, K; Papachristou, M; Fylaktou, A; Skoura, L

Dimitroulas, T; Tychala, A; Katsimpourlia, E; Sidiropoulou, E; Deuteraiou, K; Papachristou, M; Fylaktou, A; Skoura, L.

Afiliação

Dimitroulas T; Fourth Department of Internal Medicine, Hippokration Hospital, School of Medicine, Thessaloniki, Greece.
Tychala A; Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Katsimpourlia E; Department of Immunology, General Hospital G. Papanikolaou, Thessaloniki, Greece.
Sidiropoulou E; Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Deuteraiou K; Fourth Department of Internal Medicine, Hippokration Hospital, School of Medicine, Thessaloniki, Greece.
Papachristou M; Immunology Departments, National Peripheral Histocompatibility Center, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.
Fylaktou A; Immunology Departments, National Peripheral Histocompatibility Center, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.
Skoura L; Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Scand J Rheumatol ; 51(5): 422-424, 2022 09.

Article em En | MEDLINE | ID: mdl-35546492

Assuntos

Doenças Autoimunes; Coronavírus Relacionado à Síndrome Respiratória Aguda Grave; Anticorpos Antivirais; Humanos; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google